Alexandr Kuperin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alexandr Kuperin has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Evgeny I. Seliverstov
Institute of Surgery of the Pirogov Russian National Research Medical University
5 shared publications - I. S. Lebedev
Pirogov Russian National Research Medical University
5 shared publications - Igor Anatolievich Zolotukhin
Pirogov Russian National Research Medical University
5 shared publications - E.S. An
Pirogov Russian National Research Medical University
4 shared publications - Lev L. Gusev
Pirogov Russian National Research Medical University
3 shared publications - Alexey V. Vasilyiev
Pirogov Russian National Research Medical University
2 shared publications
Latest Publications
- Open Access
- 7 October 2026
- Published by Springer Nature in Systematic Reviews
Non-operative management in patients with iatrogenic colorectal perforations: protocol for a systematic review
- 7 October 2026
- Published by Springer Nature in Systematic Reviews
Open AccessNon-operative management in patients with iatrogenic colorectal perforations: protocol for a systematic review
- 26 March 2026
- Published by Media Sphere Publishing Group in Journal of Venous Disorders
- Vol. 20 (1)
Early Recurrence of Deep Vein Thrombosis after Endovascular Mechanical Thrombectomy in Proximal Deep Vein Thrombosis
The article presents a case of treatment proximal deep venous thrombosis using different endovascular approaches. The case emphasizes the importance of individualized approach, monitoring and multidisciplinary management of patients undergoing invasive treatment of deep vein thrombosis (DVT). Patient of 42 years old came with complaints of swelling and bursting pain in the left lower limb lasting 7 days. Iliofemoral venous thrombosis of the left lower limb was confirmed. The patient underwent successful aspiration thrombectomy with subsequent balloon angioplasty. The patient developed re-thrombosis with thrombus extension to the inferior vena cava despite the initial satisfactory outcome of intervention. An inferior vena cava filter was inserted and catheter-directed thrombolysis was performed, which allowed to achieve a good technical result. Attempts of inferior vena cava filter removing in the clinic were unsuccessful and it was successfully excised only in 5 months in another hospital. No DVT recurrence were observed during 12 months of follow-up. The severity of post-thrombotic syndrome was 3 points according to the Villalta scale one year after the treatment. Due to timely diagnosis and comprehensive treatment we achieved stable venous recanalization with favorable long-term outcomes. This case suggests that using only mechanical methods of thrombus extraction without catheter-directed thrombolysis is possible only in case of complete removing ofthrombotic masses.
- 26 March 2026
- Published by Media Sphere Publishing Group in Journal of Venous Disorders
- Vol. 20 (1)
Early Recurrence of Deep Vein Thrombosis after Endovascular Mechanical Thrombectomy in Proximal Deep Vein Thrombosis
The article presents a case of treatment proximal deep venous thrombosis using different endovascular approaches. The case emphasizes the importance of individualized approach, monitoring and multidisciplinary management of patients undergoing invasive treatment of deep vein thrombosis (DVT). Patient of 42 years old came with complaints of swelling and bursting pain in the left lower limb lasting 7 days. Iliofemoral venous thrombosis of the left lower limb was confirmed. The patient underwent successful aspiration thrombectomy with subsequent balloon angioplasty. The patient developed re-thrombosis with thrombus extension to the inferior vena cava despite the initial satisfactory outcome of intervention. An inferior vena cava filter was inserted and catheter-directed thrombolysis was performed, which allowed to achieve a good technical result. Attempts of inferior vena cava filter removing in the clinic were unsuccessful and it was successfully excised only in 5 months in another hospital. No DVT recurrence were observed during 12 months of follow-up. The severity of post-thrombotic syndrome was 3 points according to the Villalta scale one year after the treatment. Due to timely diagnosis and comprehensive treatment we achieved stable venous recanalization with favorable long-term outcomes. This case suggests that using only mechanical methods of thrombus extraction without catheter-directed thrombolysis is possible only in case of complete removing ofthrombotic masses.
- 27 September 2025
- Published by Media Sphere Publishing Group in Journal of Venous Disorders
- Vol. 19 (3)
Mechanical Endovascular Thromboextraction and Catheter-Directed Thrombolysis in Patients with Iliofemoral Deep Vein Thrombosis of the Lower Extremities: a Single-Center Prospective Cohort Study
Objective. To analyze the efficacy of mechanical thromboextraction (MT) and catheter-directed thrombolysis (CDT) for deep vein thrombosis (DVT) regarding post-thrombotic syndrome (PTS) and quality of life in patients with iliofemoral DVT. Material and methods. A single-center prospective cohort study (January 2022 — June 2024) included patients with iliofemoral DVT eligible for endovascular treatment. Some patients underwent MT and/or CDT. After 6 months, we assessed severity of PTS (Villalta scale) and quality of life (SF-36 and CIVIQ-20 questionnaires). Results. Among 1908 hospitalized patients with DVT, 98 ones met the criteria for invasive treatment. The procedure was performed in 21 (21%) patients. After 6 months, PTS was less severe in patients with iliofemoral DVT who underwent MT and/or CDT compared with those who received conservative treatment alone (Villalta score 3 [2; 5] and 7 [5; 9]; p<0.001). In the invasive treatment group, 71% of patients had Villalta score < 4. In the conservative treatment group, only 9.5% of patients had score < 4. According to the SF-36 questionnaire, there were significant differences in physical health (49.7±10.7 (27—70) and 43.0±9.8 (20—61); p=0.043), while mental health was similar (53 [50; 58] and 52 [49; 55]; p=0.351). According to the CIVIQ-20 questionnaire, quality of life was significantly higher in the group of invasive treatment (85 [78; 89] and 70 [64; 78]; p=0.009). Conclusions. MT and/or CDT in iliofemoral DVT reduces the likelihood and severity of post-thrombotic syndrome, as well as contributes to better quality of life throughout 6-month follow-up.
- 27 September 2025
- Published by Media Sphere Publishing Group in Journal of Venous Disorders
- Vol. 19 (3)
Mechanical Endovascular Thromboextraction and Catheter-Directed Thrombolysis in Patients with Iliofemoral Deep Vein Thrombosis of the Lower Extremities: a Single-Center Prospective Cohort Study
Objective. To analyze the efficacy of mechanical thromboextraction (MT) and catheter-directed thrombolysis (CDT) for deep vein thrombosis (DVT) regarding post-thrombotic syndrome (PTS) and quality of life in patients with iliofemoral DVT. Material and methods. A single-center prospective cohort study (January 2022 — June 2024) included patients with iliofemoral DVT eligible for endovascular treatment. Some patients underwent MT and/or CDT. After 6 months, we assessed severity of PTS (Villalta scale) and quality of life (SF-36 and CIVIQ-20 questionnaires). Results. Among 1908 hospitalized patients with DVT, 98 ones met the criteria for invasive treatment. The procedure was performed in 21 (21%) patients. After 6 months, PTS was less severe in patients with iliofemoral DVT who underwent MT and/or CDT compared with those who received conservative treatment alone (Villalta score 3 [2; 5] and 7 [5; 9]; p<0.001). In the invasive treatment group, 71% of patients had Villalta score < 4. In the conservative treatment group, only 9.5% of patients had score < 4. According to the SF-36 questionnaire, there were significant differences in physical health (49.7±10.7 (27—70) and 43.0±9.8 (20—61); p=0.043), while mental health was similar (53 [50; 58] and 52 [49; 55]; p=0.351). According to the CIVIQ-20 questionnaire, quality of life was significantly higher in the group of invasive treatment (85 [78; 89] and 70 [64; 78]; p=0.009). Conclusions. MT and/or CDT in iliofemoral DVT reduces the likelihood and severity of post-thrombotic syndrome, as well as contributes to better quality of life throughout 6-month follow-up.
- Open Access
- 29 January 2025
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 13 (3) , 102200
Mechanical thrombectomy and catheter directed thrombolysis utilization in patients with deep vein thrombosis: Analysis of a database of a tertiary hospital
- 29 January 2025
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 13 (3) , 102200
Open AccessMechanical thrombectomy and catheter directed thrombolysis utilization in patients with deep vein thrombosis: Analysis of a database of a tertiary hospital
- 13 September 2024
- Published by Media Sphere Publishing Group in Journal of Venous Disorders
- Vol. 18 (3)
Anticoagulant Therapy Flaws in Hospitalized Patients with Proximal Deep Vein Thrombosis and Their Impact on the Treatment Outcomes
Objective. To assess the effect of the adequacy of anticoagulant therapy (ACT) on the risk of pulmonary embolism (PE) in patients with proximal deep vein thrombosis. Material and methods. The analysis of a database consisting of 223 patients with proximal venous thrombosis (the thrombus location was not lower than the superficial femoral vein) was carried out. The types of detected ACT flaws and their frequency were analyzed. The role of ACT flaws in episodes of bleeding, thrombosis progression, PE, and deaths was evaluated. Results. Of the 223 patients, there were 97 women (43.5%) and 126 men (56.5%). The mean age was 63.4±16.2 years, the average hospital stay was 6.8±2.7 days. Flaws in the ACT were found in 36.3% (81 people) of cases. Among the identified flaws were: an increase in activated partial thromboplastin time (aPTT) by more than 2.5 times — 12 (5.4%) patients, lack of aPTT control in the first 3 days with unfractionated heparin (UFH) therapy — 40 people (17.9%), lack of achievement of target aPTT values in the first 3 days with UFH therapy — 20 people (13%), therapy with a reduced dose of rivaroxaban 20 mg / day in the acute phase of thrombosis without indications for dose reduction — 2 people (1.3%). 2 episodes of symptomatic PE have been recorded. In the first case, there were no ACT flaws, in the second, clinical manifestations of PE occurred in a patient receiving UFH with aPTT values equal to 26—27 seconds. There were no deaths and bleedings. In 40 patients (17.9%), an increase in the level of thrombosis was recorded against the background of ACT. The results of the logistic regression analysis showed that a statistically significant factor in increasing the level of thrombosis is the start of an act with UFH — the odds ratio is 2.52 (95% CI: 1.11—5.74) (p=0.0271). Conclusion. Most often, ACT flaws occur when UFH is prescribed due to its poorly predictable pharmacokinetics and the need for laboratory monitoring. Even though the performed ACT often has defects, it is still able to prevent the progression of VTE in most cases. Even an adequate ACT is not guaranteed to prevent an embolism.
- 13 September 2024
- Published by Media Sphere Publishing Group in Journal of Venous Disorders
- Vol. 18 (3)
Anticoagulant Therapy Flaws in Hospitalized Patients with Proximal Deep Vein Thrombosis and Their Impact on the Treatment Outcomes
Objective. To assess the effect of the adequacy of anticoagulant therapy (ACT) on the risk of pulmonary embolism (PE) in patients with proximal deep vein thrombosis. Material and methods. The analysis of a database consisting of 223 patients with proximal venous thrombosis (the thrombus location was not lower than the superficial femoral vein) was carried out. The types of detected ACT flaws and their frequency were analyzed. The role of ACT flaws in episodes of bleeding, thrombosis progression, PE, and deaths was evaluated. Results. Of the 223 patients, there were 97 women (43.5%) and 126 men (56.5%). The mean age was 63.4±16.2 years, the average hospital stay was 6.8±2.7 days. Flaws in the ACT were found in 36.3% (81 people) of cases. Among the identified flaws were: an increase in activated partial thromboplastin time (aPTT) by more than 2.5 times — 12 (5.4%) patients, lack of aPTT control in the first 3 days with unfractionated heparin (UFH) therapy — 40 people (17.9%), lack of achievement of target aPTT values in the first 3 days with UFH therapy — 20 people (13%), therapy with a reduced dose of rivaroxaban 20 mg / day in the acute phase of thrombosis without indications for dose reduction — 2 people (1.3%). 2 episodes of symptomatic PE have been recorded. In the first case, there were no ACT flaws, in the second, clinical manifestations of PE occurred in a patient receiving UFH with aPTT values equal to 26—27 seconds. There were no deaths and bleedings. In 40 patients (17.9%), an increase in the level of thrombosis was recorded against the background of ACT. The results of the logistic regression analysis showed that a statistically significant factor in increasing the level of thrombosis is the start of an act with UFH — the odds ratio is 2.52 (95% CI: 1.11—5.74) (p=0.0271). Conclusion. Most often, ACT flaws occur when UFH is prescribed due to its poorly predictable pharmacokinetics and the need for laboratory monitoring. Even though the performed ACT often has defects, it is still able to prevent the progression of VTE in most cases. Even an adequate ACT is not guaranteed to prevent an embolism.
- 17 June 2024
- Published by Media Sphere Publishing Group in Journal of Venous Disorders
- Vol. 18 (2)
Embolic Risk of Deep Vein Thrombosis is not Related to the Nature of Proximal Clot
Despite clinical guidelines not recognizing floating clots as an absolute indication for surgical prevention of pulmonary embolism (PE), many specialists adhere to active surgical approach in such cases. OBJECTIVE To evaluate the incidence of symptomatic PE in patients with proximal embolic (floating) thrombus under standard anticoagulation. MATERIAL AND METHODS We analyzed patients with proximal venous thrombosis above the femoral vein. The main group (embolic thrombosis) included 60 patients with floating clot length of 9.3±2.3 cm, the control group (non-embolic thrombosis) — 164 patients with floating clot length of 2.2±2.2 cm (pp=0.029). Proximal level of thrombosis below the inguinal ligament was found in 49 (81.6%) and 102 (62%) patients, respectively (p=0.006). Mean hospital-stay was 9.2±3.3 and 6.0±1.9 days, respectively (pp=0.952). There were no deaths in both groups. CONCLUSION Incidence of symptomatic PE is similar in patients with embolic and non-embolic deep vein thrombosis receiving adequate anticoagulation in accordance with clinical guidelines.
- 17 June 2024
- Published by Media Sphere Publishing Group in Journal of Venous Disorders
- Vol. 18 (2)
Embolic Risk of Deep Vein Thrombosis is not Related to the Nature of Proximal Clot
Despite clinical guidelines not recognizing floating clots as an absolute indication for surgical prevention of pulmonary embolism (PE), many specialists adhere to active surgical approach in such cases. OBJECTIVE To evaluate the incidence of symptomatic PE in patients with proximal embolic (floating) thrombus under standard anticoagulation. MATERIAL AND METHODS We analyzed patients with proximal venous thrombosis above the femoral vein. The main group (embolic thrombosis) included 60 patients with floating clot length of 9.3±2.3 cm, the control group (non-embolic thrombosis) — 164 patients with floating clot length of 2.2±2.2 cm (pp=0.029). Proximal level of thrombosis below the inguinal ligament was found in 49 (81.6%) and 102 (62%) patients, respectively (p=0.006). Mean hospital-stay was 9.2±3.3 and 6.0±1.9 days, respectively (pp=0.952). There were no deaths in both groups. CONCLUSION Incidence of symptomatic PE is similar in patients with embolic and non-embolic deep vein thrombosis receiving adequate anticoagulation in accordance with clinical guidelines.
- 18 March 2024
- Published by Media Sphere Publishing Group in Journal of Venous Disorders
- Vol. 18 (1)
Endovascular Management of Iliofemoral Deep Vein Thrombosis
Venous thromboembolism (VTE) is an important problem for public healthcare systems. Deep vein thrombosis (DVT) of the lower extremities leads to post-thrombotic syndrome (PTS) in 20—50% of cases. Endovascular management of DVT in patients with iliofemoral thrombosis reduces the risk of severe forms of PTS. There are various endovascular procedures including catheter-directed thrombolysis (CDT), mechanical thrombectomy (MT), and their combination. Such interventions require a multidisciplinary approach and involvement of a surgeon. Despite the long history of investigations in this field, many questions are still unresolved, i.e. implantation of cava-filter, optimal venous access and device, anticoagulant agent in acute period. Venous stents in addition to CDT or MT can improve the outcomes. Primary patency rate among different types of venous stents is identical. The choice of stent type is still up to a surgeon and depends on economic affordability as a main limiting factor. Currently, there are no standardized protocols for such endovascular procedures. There are numerous characteristics complicating this process such as disease duration, anatomical features and technical capabilities of hospitals. It is also important to consider the economic aspect of such interventions, especially when combining multiple techniques (MT and stenting). Only a small percentage of patients are potentially eligible for endovascular treatment of DVT. Therefore, these interventions are advisable in hospitals with large number of such patients.
- 18 March 2024
- Published by Media Sphere Publishing Group in Journal of Venous Disorders
- Vol. 18 (1)
Endovascular Management of Iliofemoral Deep Vein Thrombosis
Venous thromboembolism (VTE) is an important problem for public healthcare systems. Deep vein thrombosis (DVT) of the lower extremities leads to post-thrombotic syndrome (PTS) in 20—50% of cases. Endovascular management of DVT in patients with iliofemoral thrombosis reduces the risk of severe forms of PTS. There are various endovascular procedures including catheter-directed thrombolysis (CDT), mechanical thrombectomy (MT), and their combination. Such interventions require a multidisciplinary approach and involvement of a surgeon. Despite the long history of investigations in this field, many questions are still unresolved, i.e. implantation of cava-filter, optimal venous access and device, anticoagulant agent in acute period. Venous stents in addition to CDT or MT can improve the outcomes. Primary patency rate among different types of venous stents is identical. The choice of stent type is still up to a surgeon and depends on economic affordability as a main limiting factor. Currently, there are no standardized protocols for such endovascular procedures. There are numerous characteristics complicating this process such as disease duration, anatomical features and technical capabilities of hospitals. It is also important to consider the economic aspect of such interventions, especially when combining multiple techniques (MT and stenting). Only a small percentage of patients are potentially eligible for endovascular treatment of DVT. Therefore, these interventions are advisable in hospitals with large number of such patients.